nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP2E1—liver cancer	0.19	0.503	CbGaD
Nifedipine—CYP1A1—liver cancer	0.187	0.497	CbGaD
Nifedipine—ABCC3—Doxorubicin—liver cancer	0.0553	0.16	CbGbCtD
Nifedipine—ABCC2—Sorafenib—liver cancer	0.0414	0.12	CbGbCtD
Nifedipine—CYP3A7—Sorafenib—liver cancer	0.0277	0.0802	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0277	0.0802	CbGbCtD
Nifedipine—CYP2B6—Sorafenib—liver cancer	0.0264	0.0764	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—liver cancer	0.0251	0.0729	CbGbCtD
Nifedipine—CYP3A5—Sorafenib—liver cancer	0.0208	0.0602	CbGbCtD
Nifedipine—CYP2C8—Sorafenib—liver cancer	0.02	0.0579	CbGbCtD
Nifedipine—ABCC2—bile canaliculus—liver cancer	0.0198	0.381	CbGeAlD
Nifedipine—CYP2B6—Doxorubicin—liver cancer	0.016	0.0464	CbGbCtD
Nifedipine—CYP1A2—Sorafenib—liver cancer	0.0155	0.0448	CbGbCtD
Nifedipine—CYP2C9—Sorafenib—liver cancer	0.0139	0.0404	CbGbCtD
Nifedipine—ABCB1—Sorafenib—liver cancer	0.0135	0.0392	CbGbCtD
Nifedipine—CYP2D6—Sorafenib—liver cancer	0.0127	0.0369	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—liver cancer	0.0082	0.0238	CbGbCtD
Nifedipine—CYP3A4—Sorafenib—liver cancer	0.0081	0.0235	CbGbCtD
Nifedipine—ABCC3—bile duct—liver cancer	0.00773	0.149	CbGeAlD
Nifedipine—CYP2D6—Doxorubicin—liver cancer	0.00772	0.0224	CbGbCtD
Nifedipine—ABCC2—bile duct—liver cancer	0.00618	0.119	CbGeAlD
Nifedipine—CYP3A4—Doxorubicin—liver cancer	0.00491	0.0142	CbGbCtD
Nifedipine—ABCC2—bile—liver cancer	0.00475	0.0914	CbGeAlD
Nifedipine—ABCC3—gall bladder—liver cancer	0.00165	0.0318	CbGeAlD
Nifedipine—CALM2—gall bladder—liver cancer	0.00119	0.023	CbGeAlD
Nifedipine—Nimodipine—AHR—liver cancer	0.00114	0.469	CrCbGaD
Nifedipine—CALM2—embryo—liver cancer	0.000756	0.0146	CbGeAlD
Nifedipine—CALM1—embryo—liver cancer	0.000752	0.0145	CbGeAlD
Nifedipine—CYP3A7—liver—liver cancer	0.000743	0.0143	CbGeAlD
Nifedipine—CACNA1H—liver—liver cancer	0.000698	0.0134	CbGeAlD
Nifedipine—CACNB2—liver—liver cancer	0.000659	0.0127	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—liver—liver cancer	0.000632	0.0122	CbGeAlD
Nifedipine—CACNA2D1—liver—liver cancer	0.000619	0.0119	CbGeAlD
Nifedipine—CACNA1D—liver—liver cancer	0.000576	0.0111	CbGeAlD
Nifedipine—CYP2A6—liver—liver cancer	0.000516	0.00994	CbGeAlD
Nifedipine—ABCC3—liver—liver cancer	0.000483	0.00931	CbGeAlD
Nifedipine—CALM3—liver—liver cancer	0.000445	0.00858	CbGeAlD
Nifedipine—Clevidipine—CYP2E1—liver cancer	0.000387	0.159	CrCbGaD
Nifedipine—ABCC2—liver—liver cancer	0.000386	0.00744	CbGeAlD
Nifedipine—CALM2—liver—liver cancer	0.00035	0.00673	CbGeAlD
Nifedipine—CALM1—liver—liver cancer	0.000348	0.0067	CbGeAlD
Nifedipine—Nilvadipine—CYP2E1—liver cancer	0.000347	0.143	CrCbGaD
Nifedipine—ABCB1—embryo—liver cancer	0.0003	0.00579	CbGeAlD
Nifedipine—Amlodipine—CYP1A1—liver cancer	0.000294	0.121	CrCbGaD
Nifedipine—CYP2C8—liver—liver cancer	0.00029	0.00558	CbGeAlD
Nifedipine—CYP1A2—liver—liver cancer	0.000271	0.00522	CbGeAlD
Nifedipine—CYP1A1—liver—liver cancer	0.000267	0.00515	CbGeAlD
Nifedipine—Nicardipine—CYP2E1—liver cancer	0.000263	0.108	CrCbGaD
Nifedipine—CYP3A5—liver—liver cancer	0.000262	0.00504	CbGeAlD
Nifedipine—CYP2B6—liver—liver cancer	0.00026	0.00501	CbGeAlD
Nifedipine—CYP2C9—liver—liver cancer	0.000257	0.00496	CbGeAlD
Nifedipine—CYP2E1—liver—liver cancer	0.000244	0.0047	CbGeAlD
Nifedipine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000197	0.00192	CcSEcCtD
Nifedipine—Asthenia—Sorafenib—liver cancer	0.000197	0.00192	CcSEcCtD
Nifedipine—CYP3A4—liver—liver cancer	0.000196	0.00378	CbGeAlD
Nifedipine—Cardiac arrest—Epirubicin—liver cancer	0.000196	0.00191	CcSEcCtD
Nifedipine—Cardiac failure—Doxorubicin—liver cancer	0.000195	0.0019	CcSEcCtD
Nifedipine—Mood swings—Epirubicin—liver cancer	0.000195	0.0019	CcSEcCtD
Nifedipine—Pruritus—Sorafenib—liver cancer	0.000194	0.00189	CcSEcCtD
Nifedipine—Ataxia—Epirubicin—liver cancer	0.000194	0.00189	CcSEcCtD
Nifedipine—CYP2D6—liver—liver cancer	0.000193	0.00372	CbGeAlD
Nifedipine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000191	0.00186	CcSEcCtD
Nifedipine—Osteoarthritis—Doxorubicin—liver cancer	0.000191	0.00186	CcSEcCtD
Nifedipine—Pain in extremity—Doxorubicin—liver cancer	0.000191	0.00186	CcSEcCtD
Nifedipine—Diplopia—Doxorubicin—liver cancer	0.000191	0.00186	CcSEcCtD
Nifedipine—Liver function test abnormal—Epirubicin—liver cancer	0.00019	0.00185	CcSEcCtD
Nifedipine—Orthostatic hypotension—Epirubicin—liver cancer	0.000188	0.00183	CcSEcCtD
Nifedipine—Migraine—Doxorubicin—liver cancer	0.000188	0.00183	CcSEcCtD
Nifedipine—Affect lability—Doxorubicin—liver cancer	0.000188	0.00183	CcSEcCtD
Nifedipine—Diarrhoea—Sorafenib—liver cancer	0.000188	0.00183	CcSEcCtD
Nifedipine—Breast disorder—Epirubicin—liver cancer	0.000186	0.00181	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000186	0.00181	CcSEcCtD
Nifedipine—Face oedema—Doxorubicin—liver cancer	0.000184	0.00179	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000182	0.00177	CcSEcCtD
Nifedipine—Muscular weakness—Epirubicin—liver cancer	0.000182	0.00177	CcSEcCtD
Nifedipine—Cardiac arrest—Doxorubicin—liver cancer	0.000181	0.00177	CcSEcCtD
Nifedipine—Dizziness—Sorafenib—liver cancer	0.000181	0.00177	CcSEcCtD
Nifedipine—Mood swings—Doxorubicin—liver cancer	0.000181	0.00176	CcSEcCtD
Nifedipine—Abdominal distension—Epirubicin—liver cancer	0.000179	0.00175	CcSEcCtD
Nifedipine—Ataxia—Doxorubicin—liver cancer	0.000179	0.00175	CcSEcCtD
Nifedipine—Dysphagia—Epirubicin—liver cancer	0.000178	0.00174	CcSEcCtD
Nifedipine—Eosinophilia—Epirubicin—liver cancer	0.000176	0.00172	CcSEcCtD
Nifedipine—Liver function test abnormal—Doxorubicin—liver cancer	0.000176	0.00172	CcSEcCtD
Nifedipine—Vomiting—Sorafenib—liver cancer	0.000174	0.0017	CcSEcCtD
Nifedipine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000174	0.0017	CcSEcCtD
Nifedipine—Angina pectoris—Epirubicin—liver cancer	0.000174	0.00169	CcSEcCtD
Nifedipine—Rash—Sorafenib—liver cancer	0.000173	0.00168	CcSEcCtD
Nifedipine—Dermatitis—Sorafenib—liver cancer	0.000173	0.00168	CcSEcCtD
Nifedipine—Breast disorder—Doxorubicin—liver cancer	0.000172	0.00168	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000172	0.00167	CcSEcCtD
Nifedipine—Headache—Sorafenib—liver cancer	0.000172	0.00167	CcSEcCtD
Nifedipine—Muscular weakness—Doxorubicin—liver cancer	0.000168	0.00164	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000168	0.00164	CcSEcCtD
Nifedipine—Dysuria—Epirubicin—liver cancer	0.000167	0.00162	CcSEcCtD
Nifedipine—Abdominal distension—Doxorubicin—liver cancer	0.000166	0.00162	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000166	0.00161	CcSEcCtD
Nifedipine—Dysphagia—Doxorubicin—liver cancer	0.000165	0.00161	CcSEcCtD
Nifedipine—Pollakiuria—Epirubicin—liver cancer	0.000165	0.0016	CcSEcCtD
Nifedipine—Eosinophilia—Doxorubicin—liver cancer	0.000163	0.00159	CcSEcCtD
Nifedipine—Nausea—Sorafenib—liver cancer	0.000163	0.00159	CcSEcCtD
Nifedipine—Photosensitivity reaction—Epirubicin—liver cancer	0.000163	0.00158	CcSEcCtD
Nifedipine—Weight increased—Epirubicin—liver cancer	0.000162	0.00158	CcSEcCtD
Nifedipine—Weight decreased—Epirubicin—liver cancer	0.000161	0.00157	CcSEcCtD
Nifedipine—Hyperglycaemia—Epirubicin—liver cancer	0.000161	0.00157	CcSEcCtD
Nifedipine—Angina pectoris—Doxorubicin—liver cancer	0.000161	0.00156	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000157	0.00153	CcSEcCtD
Nifedipine—Jaundice—Epirubicin—liver cancer	0.000155	0.00151	CcSEcCtD
Nifedipine—Conjunctivitis—Epirubicin—liver cancer	0.000154	0.0015	CcSEcCtD
Nifedipine—Dysuria—Doxorubicin—liver cancer	0.000154	0.0015	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000153	0.00149	CcSEcCtD
Nifedipine—Sweating—Epirubicin—liver cancer	0.000152	0.00148	CcSEcCtD
Nifedipine—Pollakiuria—Doxorubicin—liver cancer	0.000152	0.00148	CcSEcCtD
Nifedipine—Haematuria—Epirubicin—liver cancer	0.000151	0.00148	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00015	0.00147	CcSEcCtD
Nifedipine—Hepatobiliary disease—Epirubicin—liver cancer	0.00015	0.00146	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—liver cancer	0.00015	0.00146	CcSEcCtD
Nifedipine—Epistaxis—Epirubicin—liver cancer	0.00015	0.00146	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—liver cancer	0.000149	0.00145	CcSEcCtD
Nifedipine—Sinusitis—Epirubicin—liver cancer	0.000149	0.00145	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—liver cancer	0.000149	0.00145	CcSEcCtD
Nifedipine—Agranulocytosis—Epirubicin—liver cancer	0.000148	0.00144	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000146	0.00142	CcSEcCtD
Nifedipine—Bradycardia—Epirubicin—liver cancer	0.000145	0.00141	CcSEcCtD
Nifedipine—Haemoglobin—Epirubicin—liver cancer	0.000143	0.0014	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—liver cancer	0.000143	0.0014	CcSEcCtD
Nifedipine—Rhinitis—Epirubicin—liver cancer	0.000143	0.00139	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—liver cancer	0.000143	0.00139	CcSEcCtD
Nifedipine—Hepatitis—Epirubicin—liver cancer	0.000143	0.00139	CcSEcCtD
Nifedipine—Haemorrhage—Epirubicin—liver cancer	0.000143	0.00139	CcSEcCtD
Nifedipine—Hypoaesthesia—Epirubicin—liver cancer	0.000142	0.00138	CcSEcCtD
Nifedipine—Pharyngitis—Epirubicin—liver cancer	0.000142	0.00138	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—liver cancer	0.000141	0.00137	CcSEcCtD
Nifedipine—Urinary tract disorder—Epirubicin—liver cancer	0.000141	0.00137	CcSEcCtD
Nifedipine—Oedema peripheral—Epirubicin—liver cancer	0.00014	0.00137	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—liver cancer	0.00014	0.00137	CcSEcCtD
Nifedipine—Connective tissue disorder—Epirubicin—liver cancer	0.00014	0.00137	CcSEcCtD
Nifedipine—Urethral disorder—Epirubicin—liver cancer	0.00014	0.00136	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000139	0.00135	CcSEcCtD
Nifedipine—ABCB1—liver—liver cancer	0.000139	0.00268	CbGeAlD
Nifedipine—Epistaxis—Doxorubicin—liver cancer	0.000139	0.00135	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—liver cancer	0.000138	0.00134	CcSEcCtD
Nifedipine—Visual impairment—Epirubicin—liver cancer	0.000137	0.00134	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—liver cancer	0.000137	0.00134	CcSEcCtD
Nifedipine—Erythema multiforme—Epirubicin—liver cancer	0.000135	0.00131	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—liver cancer	0.000134	0.00131	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—liver cancer	0.000133	0.0013	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—liver cancer	0.000133	0.0013	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—liver cancer	0.000133	0.00129	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—liver cancer	0.000132	0.00129	CcSEcCtD
Nifedipine—Flushing—Epirubicin—liver cancer	0.000132	0.00129	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—liver cancer	0.000132	0.00129	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—liver cancer	0.000132	0.00129	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—liver cancer	0.000132	0.00129	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—liver cancer	0.000131	0.00128	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—liver cancer	0.000131	0.00128	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—liver cancer	0.00013	0.00127	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—liver cancer	0.00013	0.00127	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—liver cancer	0.00013	0.00126	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—liver cancer	0.000129	0.00126	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—liver cancer	0.000129	0.00126	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—liver cancer	0.000129	0.00125	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—liver cancer	0.000128	0.00125	CcSEcCtD
Nifedipine—Chills—Epirubicin—liver cancer	0.000128	0.00125	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—liver cancer	0.000127	0.00124	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—liver cancer	0.000127	0.00124	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—liver cancer	0.000126	0.00123	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—liver cancer	0.000125	0.00122	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—liver cancer	0.000125	0.00122	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—liver cancer	0.000124	0.00121	CcSEcCtD
Nifedipine—Erythema—Epirubicin—liver cancer	0.000124	0.00121	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—liver cancer	0.000123	0.0012	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—liver cancer	0.000123	0.0012	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—liver cancer	0.000122	0.00119	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—liver cancer	0.000122	0.00119	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—liver cancer	0.000122	0.00119	CcSEcCtD
Nifedipine—Tension—Epirubicin—liver cancer	0.000122	0.00119	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—liver cancer	0.000122	0.00118	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—liver cancer	0.000121	0.00117	CcSEcCtD
Nifedipine—Back pain—Epirubicin—liver cancer	0.00012	0.00117	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—liver cancer	0.00012	0.00117	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—liver cancer	0.000119	0.00116	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—liver cancer	0.000119	0.00116	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—liver cancer	0.000119	0.00116	CcSEcCtD
Nifedipine—Chills—Doxorubicin—liver cancer	0.000118	0.00115	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—liver cancer	0.000118	0.00115	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—liver cancer	0.000117	0.00114	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—liver cancer	0.000117	0.00114	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—liver cancer	0.000116	0.00113	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—liver cancer	0.000115	0.00112	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—liver cancer	0.000115	0.00112	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—liver cancer	0.000115	0.00112	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—liver cancer	0.000115	0.00112	CcSEcCtD
Nifedipine—Agitation—Epirubicin—liver cancer	0.000114	0.00111	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—liver cancer	0.000113	0.0011	CcSEcCtD
Nifedipine—Tension—Doxorubicin—liver cancer	0.000113	0.0011	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—liver cancer	0.000112	0.0011	CcSEcCtD
Nifedipine—Malaise—Epirubicin—liver cancer	0.000112	0.00109	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—liver cancer	0.000112	0.00109	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—liver cancer	0.000112	0.00109	CcSEcCtD
Nifedipine—Syncope—Epirubicin—liver cancer	0.000111	0.00108	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—liver cancer	0.000111	0.00108	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—liver cancer	0.000111	0.00108	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—liver cancer	0.00011	0.00108	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—liver cancer	0.00011	0.00107	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—liver cancer	0.000109	0.00106	CcSEcCtD
Nifedipine—Cough—Epirubicin—liver cancer	0.000108	0.00106	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—liver cancer	0.000108	0.00105	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—liver cancer	0.000107	0.00104	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—liver cancer	0.000106	0.00103	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—liver cancer	0.000106	0.00103	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—liver cancer	0.000106	0.00103	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—liver cancer	0.000106	0.00103	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—liver cancer	0.000106	0.00103	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—liver cancer	0.000105	0.00103	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000105	0.00102	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—liver cancer	0.000104	0.00102	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—liver cancer	0.000104	0.00101	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—liver cancer	0.000103	0.00101	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—liver cancer	0.000103	0.00101	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—liver cancer	0.000103	0.001	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—liver cancer	0.000103	0.001	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—liver cancer	0.000102	0.000995	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—liver cancer	0.000101	0.000989	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—liver cancer	0.000101	0.000987	CcSEcCtD
Nifedipine—Oedema—Epirubicin—liver cancer	0.000101	0.000987	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—liver cancer	0.000101	0.000984	CcSEcCtD
Nifedipine—Cough—Doxorubicin—liver cancer	0.0001	0.000977	CcSEcCtD
Nifedipine—Shock—Epirubicin—liver cancer	9.97e-05	0.000971	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—liver cancer	9.93e-05	0.000968	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—liver cancer	9.92e-05	0.000966	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—liver cancer	9.89e-05	0.000963	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—liver cancer	9.84e-05	0.000959	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—liver cancer	9.79e-05	0.000954	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—liver cancer	9.78e-05	0.000953	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—liver cancer	9.78e-05	0.000953	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—liver cancer	9.78e-05	0.000953	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—liver cancer	9.74e-05	0.000949	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.71e-05	0.000946	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—liver cancer	9.66e-05	0.000941	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—liver cancer	9.66e-05	0.000941	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—liver cancer	9.56e-05	0.000932	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—liver cancer	9.47e-05	0.000922	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—liver cancer	9.45e-05	0.000921	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—liver cancer	9.37e-05	0.000913	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—liver cancer	9.37e-05	0.000913	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—liver cancer	9.23e-05	0.000899	CcSEcCtD
Nifedipine—Shock—Doxorubicin—liver cancer	9.22e-05	0.000899	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—liver cancer	9.19e-05	0.000896	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—liver cancer	9.18e-05	0.000894	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—liver cancer	9.16e-05	0.000893	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—liver cancer	9.15e-05	0.000891	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—liver cancer	9.1e-05	0.000887	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—liver cancer	9.1e-05	0.000886	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—liver cancer	9.06e-05	0.000883	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—liver cancer	9.03e-05	0.00088	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—liver cancer	9.01e-05	0.000877	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—liver cancer	8.93e-05	0.000871	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—liver cancer	8.92e-05	0.000869	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—liver cancer	8.81e-05	0.000858	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—liver cancer	8.76e-05	0.000853	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—liver cancer	8.75e-05	0.000852	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—liver cancer	8.73e-05	0.000851	CcSEcCtD
Nifedipine—Pain—Epirubicin—liver cancer	8.66e-05	0.000844	CcSEcCtD
Nifedipine—Constipation—Epirubicin—liver cancer	8.66e-05	0.000844	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—liver cancer	8.54e-05	0.000832	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—liver cancer	8.48e-05	0.000826	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—liver cancer	8.42e-05	0.00082	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—liver cancer	8.36e-05	0.000814	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—liver cancer	8.35e-05	0.000813	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—liver cancer	8.33e-05	0.000812	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—liver cancer	8.28e-05	0.000807	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—liver cancer	8.25e-05	0.000804	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—liver cancer	8.15e-05	0.000794	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—liver cancer	8.09e-05	0.000788	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—liver cancer	8.08e-05	0.000787	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—liver cancer	8.05e-05	0.000784	CcSEcCtD
Nifedipine—Pain—Doxorubicin—liver cancer	8.01e-05	0.000781	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—liver cancer	8.01e-05	0.000781	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—liver cancer	8.01e-05	0.00078	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—liver cancer	8.01e-05	0.00078	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—liver cancer	7.72e-05	0.000753	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—liver cancer	7.66e-05	0.000747	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—liver cancer	7.46e-05	0.000727	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—liver cancer	7.45e-05	0.000726	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—liver cancer	7.41e-05	0.000722	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—liver cancer	7.41e-05	0.000722	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—liver cancer	7.27e-05	0.000708	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—liver cancer	7.17e-05	0.000698	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—liver cancer	6.93e-05	0.000675	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—liver cancer	6.91e-05	0.000673	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—liver cancer	6.72e-05	0.000655	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—liver cancer	6.7e-05	0.000653	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—liver cancer	6.63e-05	0.000646	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—liver cancer	6.44e-05	0.000628	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—liver cancer	6.41e-05	0.000625	CcSEcCtD
Nifedipine—Rash—Epirubicin—liver cancer	6.39e-05	0.000622	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—liver cancer	6.38e-05	0.000622	CcSEcCtD
Nifedipine—Headache—Epirubicin—liver cancer	6.35e-05	0.000618	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—liver cancer	6.2e-05	0.000604	CcSEcCtD
Nifedipine—Nausea—Epirubicin—liver cancer	6.02e-05	0.000586	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—liver cancer	5.96e-05	0.000581	CcSEcCtD
Nifedipine—Rash—Doxorubicin—liver cancer	5.91e-05	0.000576	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—liver cancer	5.9e-05	0.000575	CcSEcCtD
Nifedipine—Headache—Doxorubicin—liver cancer	5.87e-05	0.000572	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—liver cancer	5.57e-05	0.000542	CcSEcCtD
Nifedipine—CALM1—Immune System—CTNNB1—liver cancer	2.84e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—AKT1—liver cancer	2.84e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—F2—liver cancer	2.83e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—F2—liver cancer	2.83e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—MTHFR—liver cancer	2.82e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PPARG—liver cancer	2.81e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ALB—liver cancer	2.81e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ALB—liver cancer	2.81e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK8—liver cancer	2.8e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CG—liver cancer	2.8e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—APC—liver cancer	2.8e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CD—liver cancer	2.79e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARA—liver cancer	2.79e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CDKN1B—liver cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CDKN1B—liver cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CDKN1A—liver cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CDKN1A—liver cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.78e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARA—liver cancer	2.77e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ALB—liver cancer	2.76e-06	2.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—AKT1—liver cancer	2.74e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—AKT1—liver cancer	2.74e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTM1—liver cancer	2.73e-06	2.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—AKT1—liver cancer	2.72e-06	2.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CTNNB1—liver cancer	2.72e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK8—liver cancer	2.71e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK8—liver cancer	2.71e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CG—liver cancer	2.71e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CG—liver cancer	2.71e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APC—liver cancer	2.71e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APC—liver cancer	2.71e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CDKN1A—liver cancer	2.65e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CB—liver cancer	2.64e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—liver cancer	2.63e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—liver cancer	2.63e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—BRAF—liver cancer	2.63e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CTNNB1—liver cancer	2.63e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CTNNB1—liver cancer	2.63e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYCS—liver cancer	2.6e-06	2.14e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—liver cancer	2.6e-06	2.14e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP1A1—liver cancer	2.59e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CB—liver cancer	2.58e-06	2.12e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CB—liver cancer	2.58e-06	2.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CDKN1A—liver cancer	2.57e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CDKN1A—liver cancer	2.57e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CB—liver cancer	2.56e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—STAT3—liver cancer	2.56e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CD—liver cancer	2.56e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GOT1—liver cancer	2.55e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GGT1—liver cancer	2.55e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—BRAF—liver cancer	2.55e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—BRAF—liver cancer	2.55e-06	2.09e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CG—liver cancer	2.54e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ALB—liver cancer	2.53e-06	2.08e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.49e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CB—liver cancer	2.48e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CB—liver cancer	2.48e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—STAT3—liver cancer	2.48e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—STAT3—liver cancer	2.48e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CD—liver cancer	2.46e-06	2.02e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—liver cancer	2.45e-06	2.01e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CB—liver cancer	2.43e-06	2e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SERPINE1—liver cancer	2.43e-06	2e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—liver cancer	2.41e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—liver cancer	2.41e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—liver cancer	2.39e-06	1.97e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—liver cancer	2.38e-06	1.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—liver cancer	2.38e-06	1.96e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—liver cancer	2.37e-06	1.95e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—liver cancer	2.37e-06	1.95e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARA—liver cancer	2.36e-06	1.95e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SERPINE1—liver cancer	2.35e-06	1.94e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SERPINE1—liver cancer	2.35e-06	1.94e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—liver cancer	2.33e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—liver cancer	2.33e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—liver cancer	2.31e-06	1.9e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—liver cancer	2.29e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—liver cancer	2.29e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—liver cancer	2.29e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—liver cancer	2.29e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMOX1—liver cancer	2.26e-06	1.86e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—liver cancer	2.23e-06	1.84e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—liver cancer	2.23e-06	1.83e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—liver cancer	2.21e-06	1.82e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—liver cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—liver cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—liver cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RAF1—liver cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—liver cancer	2.19e-06	1.8e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—liver cancer	2.17e-06	1.79e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MTOR—liver cancer	2.14e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—liver cancer	2.14e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—liver cancer	2.14e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—liver cancer	2.14e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—liver cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—liver cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—liver cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—liver cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RAF1—liver cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RAF1—liver cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.12e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—liver cancer	2.12e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—liver cancer	2.12e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—liver cancer	2.1e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—liver cancer	2.1e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—liver cancer	2.08e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—liver cancer	2.07e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—liver cancer	2.07e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MTOR—liver cancer	2.07e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MTOR—liver cancer	2.07e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—liver cancer	2.07e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—liver cancer	2.06e-06	1.69e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—liver cancer	2.05e-06	1.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—liver cancer	2.03e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—liver cancer	2.03e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—liver cancer	2.02e-06	1.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—liver cancer	2.01e-06	1.66e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A1—liver cancer	2e-06	1.64e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—liver cancer	1.99e-06	1.64e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—liver cancer	1.98e-06	1.63e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—liver cancer	1.98e-06	1.63e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—liver cancer	1.97e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—liver cancer	1.97e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—liver cancer	1.97e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—liver cancer	1.97e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—liver cancer	1.96e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—liver cancer	1.96e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—liver cancer	1.96e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—liver cancer	1.95e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—liver cancer	1.95e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—liver cancer	1.95e-06	1.6e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—liver cancer	1.94e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—liver cancer	1.92e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—liver cancer	1.92e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—liver cancer	1.91e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—liver cancer	1.91e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—liver cancer	1.91e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—liver cancer	1.91e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—liver cancer	1.9e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—liver cancer	1.9e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—liver cancer	1.9e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—liver cancer	1.87e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—liver cancer	1.87e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—liver cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—liver cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—liver cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—liver cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—liver cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—liver cancer	1.85e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—liver cancer	1.85e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—liver cancer	1.84e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—liver cancer	1.84e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.83e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARA—liver cancer	1.83e-06	1.5e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.82e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK8—liver cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—liver cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—liver cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—liver cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—liver cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—liver cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—liver cancer	1.8e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—liver cancer	1.8e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—liver cancer	1.8e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—liver cancer	1.8e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—liver cancer	1.79e-06	1.47e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.78e-06	1.46e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—liver cancer	1.77e-06	1.46e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—liver cancer	1.76e-06	1.45e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK8—liver cancer	1.75e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK8—liver cancer	1.75e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—liver cancer	1.75e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—liver cancer	1.75e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—liver cancer	1.73e-06	1.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—liver cancer	1.73e-06	1.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—liver cancer	1.73e-06	1.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—liver cancer	1.67e-06	1.38e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—liver cancer	1.67e-06	1.37e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—liver cancer	1.67e-06	1.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—liver cancer	1.66e-06	1.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—liver cancer	1.65e-06	1.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—liver cancer	1.65e-06	1.36e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—liver cancer	1.63e-06	1.34e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—liver cancer	1.62e-06	1.33e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—liver cancer	1.62e-06	1.33e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—liver cancer	1.61e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—liver cancer	1.6e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—liver cancer	1.6e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—liver cancer	1.6e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—liver cancer	1.6e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—liver cancer	1.6e-06	1.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—liver cancer	1.6e-06	1.31e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—liver cancer	1.57e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—liver cancer	1.57e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—liver cancer	1.56e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.56e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—liver cancer	1.55e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—liver cancer	1.54e-06	1.27e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—liver cancer	1.54e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—liver cancer	1.53e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—liver cancer	1.51e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—liver cancer	1.51e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—liver cancer	1.51e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—liver cancer	1.49e-06	1.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—liver cancer	1.49e-06	1.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—liver cancer	1.49e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—liver cancer	1.49e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—liver cancer	1.48e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—liver cancer	1.48e-06	1.21e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—liver cancer	1.48e-06	1.21e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—liver cancer	1.42e-06	1.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—liver cancer	1.38e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—liver cancer	1.38e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.37e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—liver cancer	1.36e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—liver cancer	1.36e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—liver cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—liver cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—liver cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—liver cancer	1.28e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—liver cancer	1.28e-06	1.05e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—liver cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—liver cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—liver cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—liver cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—liver cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—liver cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—liver cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—liver cancer	1.21e-06	9.97e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—liver cancer	1.21e-06	9.95e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.2e-06	9.85e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—liver cancer	1.19e-06	9.75e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—liver cancer	1.17e-06	9.63e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—liver cancer	1.17e-06	9.63e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—liver cancer	1.16e-06	9.52e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—liver cancer	1.12e-06	9.21e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—liver cancer	1.12e-06	9.21e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.12e-06	9.19e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—liver cancer	1.11e-06	9.14e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.11e-06	9.11e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—liver cancer	1.07e-06	8.79e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—liver cancer	1.03e-06	8.5e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—liver cancer	1.03e-06	8.5e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—liver cancer	9.68e-07	7.96e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—liver cancer	9.46e-07	7.78e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—liver cancer	9.12e-07	7.5e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—liver cancer	9.04e-07	7.44e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—liver cancer	7.73e-07	6.36e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—liver cancer	7.3e-07	6.01e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—liver cancer	5.96e-07	4.91e-06	CbGpPWpGaD
